Haduong JH, Heske CM, Allen‐Rhoades W, et al. An update on rhabdomyosarcoma risk stratification and the rationale for current and future children’s Oncology Group Clinical Trials. Pediatr Blood Cancer. 2022;69(4).
Linardic CM, Wexler, LH. Chapter 25: Rhabdomyosarcoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Principles and Practice of Pediatric Oncology. 8th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2021.
McEvoy MT, Siegel DA, Dai S, et al. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017. Cancer Med. 2022;12(3):3644-3656.
Raney RB, Anderson JR, Barr FG, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol. 2001;23(4):215-220.